A comparative study of the effects of yohimbine and anetholtrithione on salivary secretion in depressed patients treated with psychotropic drugs.
The present study compares the effects of yohimbine, an alpha 2 adrenoceptor antagonist, and anetholtrithione, a reference drug in the treatment of dry mouth, in patients treated with psychotropic drugs (tricyclic antidepressants or neuroleptics) and suffering from xerostomia. Ten patients were included in a randomized, double-blind, cross-over study, and receiving after yohimbine (3 x 6 mg per day) or anetholtrithione (3 x 25 mg per day) orally for 5 days. Salivary secretion was estimated under resting conditions, before any drug, and then on day 6, 1 h after the ingestion of yohimbine or anetholtrithione. Compared with basal secretion, the increase in salivary flow was significantly more marked after yohimbine than after anetholtrithione. This study demonstrates the sialogenic effect of yohimbine in drug-induced dry mouth.